Solventum Corporation

69.78-1.14 (-1.61%)
Oct 29, 4:00:02 PM EDT · NYSE · SOLV · USD

Upcoming Earnings

Report date
Nov 6, 2025 (in 7 days)

Key Stats

Market Cap
12.10B
P/E (TTM)
32.01
Basic EPS (TTM)
2.18
Dividend Yield
0%

Recent Filings

About

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

CEO
Mr. Bryan C. Hanson
IPO
3/26/2024
Employees
22,000
Sector
Healthcare
Industry
Medical Instruments & Supplies